GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Inventories, Raw Materials & Components

Haleon (Haleon) Inventories, Raw Materials & Components : $0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Inventories, Raw Materials & Components?

Haleon's inventories, raw materials & components for the quarter that ended in Mar. 2024 was $0 Mil.

Haleon's quarterly raw materials increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($377 Mil) but then declined from Dec. 2023 ($377 Mil) to Mar. 2024 ($0 Mil).

Haleon's annual raw materials increased from Dec. 2021 ($310 Mil) to Dec. 2022 ($378 Mil) but then declined from Dec. 2022 ($378 Mil) to Dec. 2023 ($377 Mil).

Haleon Inventories, Raw Materials & Components Historical Data

The historical data trend for Haleon's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Inventories, Raw Materials & Components Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
314.55 310.48 309.84 377.59 377.22

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 377.22 -

Haleon Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Haleon (Haleon) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
LSE:HIK LSE:HCM LSE:INDV LSE:BMK LSE:APH LSE:ANCR LSE:EAH LSE:AGY LSE:CEL LSE:STX ZTS XTER:MRK TSE:4502 NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX
Traded in Other Exchanges
HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Website
https://www.haleon.com
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.